KAPLAN GILLA

CIK 00012470244 companiesSUMMIT, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001247024

Recent Transactions

50 trades

Sale
Tyra Biosciences, Inc.$TYRA
Common Stock
2025-06-18$9.78/sh−9,568→ 28,231 total
Award
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2025-06-17+20,100→ 20,100 total
Sale
Tyra Biosciences, Inc.$TYRA
Common Stock
2025-06-17$10.35/sh−10→ 37,799 total
Sale
Tyra Biosciences, Inc.$TYRA
Common Stock
2025-06-16$10.38/sh−6,814→ 37,809 total
Sale
Tyra Biosciences, Inc.$TYRA
Common Stock
2025-06-13$10.31/sh−15,000→ 44,623 total
Sale
Tyra Biosciences, Inc.$TYRA
Common Stock
2025-06-12$10.31/sh−30,000→ 59,623 total
Award
Tyra Biosciences, Inc.$TYRA
Stock Option (Right to Buy)
2025-05-29+22,200→ 22,200 total
Exercise/Conversion
Avalo Therapeutics, Inc.$AVTX
Restricted Stock Units
2025-03-28−3,167→ 6,333 total
Exercise/Conversion
Avalo Therapeutics, Inc.$AVTX
Common Stock
2025-03-28+3,167→ 3,167 total
Award
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2024-08-13+24,600→ 24,600 total
Award
Avalo Therapeutics, Inc.$AVTX
Restricted Stock Units
2024-08-13+9,500→ 9,500 total
Exercise/Conversion
Tyra Biosciences, Inc.$TYRA
Common Stock
2024-06-13$0.61/sh+61,392→ 89,623 total
Exercise/Conversion
Tyra Biosciences, Inc.$TYRA
Stock Option (Right to Buy)
2024-06-13−61,392→ 0 total
Award
Tyra Biosciences, Inc.$TYRA
Stock Option (Right to Buy)
2024-05-29+18,600→ 18,600 total
Award
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2023-12-20+3,334→ 3,334 total
Award
Tyra Biosciences, Inc.$TYRA
Stock Option (Right to Buy)
2023-05-31+14,500→ 14,500 total
Award
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2022-09-30+3,080→ 3,080 total
Award
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2022-06-30+44,115→ 44,115 total
Award
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2022-06-14+40,000→ 40,000 total
Award
Tyra Biosciences, Inc.$TYRA
Stock Option (Right to Buy)
2022-06-13+14,500→ 14,500 total
Award
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2022-03-31+30,359→ 30,359 total
Award
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2021-12-31+12,767→ 12,767 total
Award
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2021-09-30+9,541→ 9,541 total
Award
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2021-06-30+6,353→ 6,353 total
Award
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2021-06-15+40,000→ 40,000 total
Award
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2021-03-31+7,650→ 7,650 total
Award
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2020-12-31+7,216→ 7,216 total
Award
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2020-10-08+50,000→ 50,000 total
Exercise/Conversion
CELGENE CORP /DE/
Common Stock
2018-05-18$30.01/sh+27,750→ 104,051 total
Exercise/Conversion
CELGENE CORP /DE/
Stock Option (right to buy)
2018-05-18−27,750→ 0 total
Sale
CELGENE CORP /DE/
Common Stock
2018-05-18$78.66/sh−27,750→ 76,301 total
Sale
CELGENE CORP /DE/
Common Stock
2018-02-20$94.83/sh−9,250→ 76,301 total
Exercise/Conversion
CELGENE CORP /DE/
Stock Option (right to buy)
2018-02-15−9,250→ 0 total
Exercise/Conversion
CELGENE CORP /DE/
Common Stock
2018-02-15$27.18/sh+9,250→ 94,801 total
Sale
CELGENE CORP /DE/
Common Stock
2018-02-15$95.99/sh−9,250→ 85,551 total
Exercise/Conversion
CELGENE CORP /DE/
Stock Option (right to buy)
2017-12-05−9,250→ 0 total
Exercise/Conversion
CELGENE CORP /DE/
Common Stock
2017-12-05$24.96/sh+9,250→ 85,551 total
Sale
CELGENE CORP /DE/
Common Stock
2017-09-12$141.56/sh−9,250→ 76,301 total
Exercise/Conversion
CELGENE CORP /DE/
Stock Option (right to buy)
2017-09-12−9,250→ 0 total
Exercise/Conversion
CELGENE CORP /DE/
Common Stock
2017-09-12$33.88/sh+9,250→ 85,551 total
Sale
CELGENE CORP /DE/
Common Stock
2017-08-02$134.52/sh−7,500→ 76,301 total
Exercise/Conversion
CELGENE CORP /DE/
Common Stock
2017-07-01+734→ 83,801 total
Exercise/Conversion
CELGENE CORP /DE/
Restricted Stock Unit
2017-07-01−734→ 0 total
Exercise/Conversion
CELGENE CORP /DE/
Common Stock
2017-06-17+333→ 83,067 total
Exercise/Conversion
CELGENE CORP /DE/
Restricted Stock Unit
2017-06-17−333→ 334 total
Exercise/Conversion
CELGENE CORP /DE/
Common Stock
2017-06-15+375→ 82,734 total
Exercise/Conversion
CELGENE CORP /DE/
Restricted Stock Unit
2017-06-15−375→ 750 total
Award
CELGENE CORP /DE/
Restricted Stock Unit
2017-06-14+900→ 900 total
Award
CELGENE CORP /DE/
Stock Option (right to buy)
2017-06-14+10,500→ 10,500 total
Exercise/Conversion
CELGENE CORP /DE/
Stock Option (right to buy)
2017-06-01−9,250→ 0 total

Companies

Recent Filings

Address

C/O CELGENE CORPORATION 86 MORRIS AVENUE

SUMMIT, NJ, 07901

View on SEC.gov